Company Filing History:
Years Active: 2024-2025
Title: The Innovative Journey of Jordan Dubow
Introduction
Jordan Dubow, an accomplished inventor based in Lyons, France, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 12 patents. His work predominantly focuses on improving the pharmacokinetic properties of gamma-hydroxybutyrate formulations, showcasing his commitment to advancing medicinal science.
Latest Patents
Among his latest groundbreaking patents are:
1. **Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics** - This innovation provides modified release formulations of gamma-hydroxybutyrate with enhanced dissolution and pharmacokinetic properties, along with their therapeutic uses.
2. **Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state** - This patent introduces oral pharmaceutical compositions of sodium oxybate designed to exhibit better pharmacokinetic properties when administered less than two hours after a meal, along with their therapeutic applications.
Career Highlights
Jordan currently works at Flamel Ireland Limited, where he continuously strives to innovate and improve pharmaceutical products. His expertise in the field has not only advanced his own career but also contributed to the overall mission of the company in delivering effective healthcare solutions.
Collaborations
Throughout his career, Jordan has collaborated with notable colleagues such as Hervé Guillard and Claire Mégret, leveraging their combined expertise and knowledge to push the boundaries of pharmaceutical research and development. These collaborative efforts have been instrumental in creating innovative products that address pressing health concerns.
Conclusion
Jordan Dubow exemplifies the spirit of innovation in the pharmaceutical industry. With a robust portfolio of patents and a dedication to collaboration, he continues to make strides in the development of effective medications. His contributions are paving the way for future advancements in pharmacology, benefiting patients around the world.